Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9025 Balboa Ave Ste 100, San Diego, Cali...Phone Number
(858) 571-1800Website
www.therapeuticsinc.comRevenue
$25.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
2
1
1
About Therapeutics
Therapeutics Inc. is a specialized dermatology Contract Research Organization (CRO) that offers integrated, turnkey solutions for drug development, navigating the complexities of non-clinical, clinical, and regulatory processes. With over 20 years of experience, the company is committed to enhancing dermatology drug development through clarity and collaboration. Their comprehensive services include product development, clinical development, and regulatory affairs, tailored to meet the unique needs of their clients. Therapeutics Inc. aims to facilitate seamless communication and workflow to ensure stakeholder satisfaction and successful regulatory approvals.Explore more
Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Therapeutics launches new products
Check out if Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Therapeutics had a recent Job posting/layoffs
Check if Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Therapeutics
Earning: See what the market has to say on Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Therapeutics
Compare insights from companies similar to Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$15.5M
51-200
Private
$31M
2003
JH
James HavilandVice President, Quality Assurance, Regulatory Compliance & Regulatory Affairs
Company Profile Activity
Activity Insights
Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Therapeutics.
Therapeutics financials insights
Gather financial insights about Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
2021
Debt
$1.3M
Therapeutics Tech Stack
A closer look at the technologies used by Therapeutics
Most Recent Scoops
Funding
Project
received an award of $294,948 on August 11, 2023 by HHS NIH with an award end date of July 31, 2024.
Award, Spending/Investment
Funding
Project
Spending/Investment
Funding
Project
Award, Spending/Investment
Open Position
Open Position
Therapeutics News & Media
Rise Therapeutics Completes Enrollment in Four-Week Dose Expansion Cohort for the R-2487 Rheumatoid Arthritis Clinical Trial
ROCKVILLE, MD, June 2, 2026 /PRNewswire/ -- Rise Therapeutics, a clinical-stage biotechnology company advancing novel oral immunotherapies for autoimmune diseases, today announced the completion of full enrollment in the 4-week dose expansion cohort of its Phase 1b clinical trial...Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy
MEQUON, Wis., June 2, 2026 /PRNewswire/ -- Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the grant of 206,610 stock options (the "Options") to certain directors of the Company in accordance with the...Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors.
This oncology-focused biotech, advancing kinase inhibitors for cancer, reported a notable insider sale amid strong one-year stock gains.Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
— Edgewise to Receive $1.55 Billion in Upfront Cash Consideration and is Eligible to Receive up to $1.1 Billion in Regulatory and Commercial Milestones — — Transaction Creates Focused Cardiovascular Company with Enhanced Strategic Clarity — — Upfront Proceeds Expected to Fully Fund...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Therapeutics
Sign Up For FreeTo access detailed company insights
Therapeutics Inc. is a specialized dermatology Contract Research Organization (CRO) that offers integrated, turnkey solutions for drug development, navigating the complexities of non-clinical, clinical, and regulatory processes. With over 20 years of experience, the company is committed to enhancing dermatology drug development through clarity and... Read More
